Complications and adverse events in lymphadenectomy of the inguinal area: worldwide expert consensus.

Humans Lymph Node Excision / adverse effects Female Male Penile Neoplasms / surgery Postoperative Complications / etiology Vulvar Neoplasms / surgery Consensus Melanoma / surgery Delphi Technique Inguinal Canal / surgery Surveys and Questionnaires

Journal

BJS open
ISSN: 2474-9842
Titre abrégé: BJS Open
Pays: England
ID NLM: 101722685

Informations de publication

Date de publication:
02 Jul 2024
Historique:
received: 25 09 2023
revised: 01 04 2024
accepted: 09 04 2024
medline: 11 7 2024
pubmed: 11 7 2024
entrez: 10 7 2024
Statut: ppublish

Résumé

Inguinal lymph node dissection plays an important role in the management of melanoma, penile and vulval cancer. Inguinal lymph node dissection is associated with various intraoperative and postoperative complications with significant heterogeneity in classification and reporting. This lack of standardization challenges efforts to study and report inguinal lymph node dissection outcomes. The aim of this study was to devise a system to standardize the classification and reporting of inguinal lymph node dissection perioperative complications by creating a worldwide collaborative, the complications and adverse events in lymphadenectomy of the inguinal area (CALI) group. A modified 3-round Delphi consensus approach surveyed a worldwide group of experts in inguinal lymph node dissection for melanoma, penile and vulval cancer. The group of experts included general surgeons, urologists and oncologists (gynaecological and surgical). The survey assessed expert agreement on inguinal lymph node dissection perioperative complications. Panel interrater agreement and consistency were assessed as the overall percentage agreement and Cronbach's α. Forty-seven experienced consultants were enrolled: 26 (55.3%) urologists, 11 (23.4%) surgical oncologists, 6 (12.8%) general surgeons and 4 (8.5%) gynaecology oncologists. Based on their expertise, 31 (66%), 10 (21.3%) and 22 (46.8%) of the participants treat penile cancer, vulval cancer and melanoma using inguinal lymph node dissection respectively; 89.4% (42 of 47) agreed with the definitions and inclusion as part of the inguinal lymph node dissection intraoperative complication group, while 93.6% (44 of 47) agreed that postoperative complications should be subclassified into five macrocategories. Unanimous agreement (100%, 37 of 37) was achieved with the final standardized classification system for reporting inguinal lymph node dissection complications in melanoma, vulval cancer and penile cancer. The complications and adverse events in lymphadenectomy of the inguinal area classification system has been developed as a tool to standardize the assessment and reporting of complications during inguinal lymph node dissection for the treatment of melanoma, vulval and penile cancer.

Sections du résumé

BACKGROUND BACKGROUND
Inguinal lymph node dissection plays an important role in the management of melanoma, penile and vulval cancer. Inguinal lymph node dissection is associated with various intraoperative and postoperative complications with significant heterogeneity in classification and reporting. This lack of standardization challenges efforts to study and report inguinal lymph node dissection outcomes. The aim of this study was to devise a system to standardize the classification and reporting of inguinal lymph node dissection perioperative complications by creating a worldwide collaborative, the complications and adverse events in lymphadenectomy of the inguinal area (CALI) group.
METHODS METHODS
A modified 3-round Delphi consensus approach surveyed a worldwide group of experts in inguinal lymph node dissection for melanoma, penile and vulval cancer. The group of experts included general surgeons, urologists and oncologists (gynaecological and surgical). The survey assessed expert agreement on inguinal lymph node dissection perioperative complications. Panel interrater agreement and consistency were assessed as the overall percentage agreement and Cronbach's α.
RESULTS RESULTS
Forty-seven experienced consultants were enrolled: 26 (55.3%) urologists, 11 (23.4%) surgical oncologists, 6 (12.8%) general surgeons and 4 (8.5%) gynaecology oncologists. Based on their expertise, 31 (66%), 10 (21.3%) and 22 (46.8%) of the participants treat penile cancer, vulval cancer and melanoma using inguinal lymph node dissection respectively; 89.4% (42 of 47) agreed with the definitions and inclusion as part of the inguinal lymph node dissection intraoperative complication group, while 93.6% (44 of 47) agreed that postoperative complications should be subclassified into five macrocategories. Unanimous agreement (100%, 37 of 37) was achieved with the final standardized classification system for reporting inguinal lymph node dissection complications in melanoma, vulval cancer and penile cancer.
CONCLUSION CONCLUSIONS
The complications and adverse events in lymphadenectomy of the inguinal area classification system has been developed as a tool to standardize the assessment and reporting of complications during inguinal lymph node dissection for the treatment of melanoma, vulval and penile cancer.

Identifiants

DOI: 10.1093/bjsopen/zrae056 PMID: 38987232
pubmed: 38987232
pii: 7710789
doi: 10.1093/bjsopen/zrae056
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of BJS Foundation Ltd.

Auteurs

René Sotelo (R)

Catherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Aref S Sayegh (AS)

Catherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Department of Surgery, MedStar Franklin Square Medical Center, Baltimore, Maryland, USA.
ORCID: 0000-0001-9320-2987

Luis G Medina (LG)

Catherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Laura C Perez (LC)

Catherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Anibal La Riva (A)

Catherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Department of General Surgery, Digestive Disease & Surgery Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Michael B Eppler (MB)

Catherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

José Gaona (J)

Universidad de Santander, Instituto Uromédica, Bucaramanga, Colombia.

Marcos Tobias-Machado (M)

Department of Urology, Instituto do Câncer Arnaldo Vieira de Carvalho, São Paulo, Brazil.

Philippe E Spiess (PE)

Department of Genitourinary Oncology and Tumor Biology, Moffitt Cancer Center, Tampa, Florida, USA.

Curtis A Pettaway (CA)

The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA.

Antonio Carlos Lima Pompeo (AC)

Department of Urology, Faculdade de Medicina do ABC, São Paulo, Brazil.

Pablo Aloisio Lima Mattos (PA)

Department of Urology, Associação Piauiense de Combate ao Câncer, Teresina, Piauí, Brazil.

Timothy G Wilson (TG)

Department of Urology, Providence St. John's Cancer Institute, Santa Monica, California, USA.

Gustavo M Villoldo (GM)

Department of Urology, Instituto Alexander Fleming, Buenos Aires, Argentina.

Eric Chung (E)

Department of Urology, Princess Alexandra Hospital, University of Queensland, Brisbane, Queensland, Australia.
ORCID: 0000-0003-3373-3668

Aldo Samaniego (A)

Department of Urology, Servicio de Urología del Hospital Central del Instituto de Previsión Social, Asunción, Paraguay.

Antonio Augusto Ornellas (AA)

Departamento de Urologia, Instituto Nacional do Câncer do Brasil (INCA), Rio de Janeiro, Brazil.

Vladimir Pinheiro (V)

Department of Urology, AC Camargo Cancer Center, São Paulo, Brazil.

Eder S Brazão (ES)

Department of Urology, AC Camargo Cancer Center, São Paulo, Brazil.

David Subira-Rios (D)

Department of Urology, Gregorio Marañon Universitary Hospital, Madrid, Spain.

Leandro Koifman (L)

Serviço de Urologia, Hospital Municipal Souza Aguiar, Rio de Janeiro, Rio de Janeiro, Brazil.

Stênio de Cassio Zequi (SC)

Department of Urology, AC Camargo Cancer Center-São Paulo, São Paulo, Brazil.
Department of Urology, National Institute for Science and Technology in Oncogenomics and Therapeutic Innovation, São Paulo, Brazil.
Graduate School of Urology, Escola Paulista de Medicina-Universidade Federal de São Paulo, São Paulo, Brazil.

Humberto M Pontillo Z (HM)

Department of Urology, Sant Jaume of Calella Hospital, Barcelona, Spain.

José de Ribamar Rodrigues Calixto (JR)

Department of Medicine II, Federal University of Maranhão, São Luís, Massachusetts, Brazil.

Rafael Campos Silva (R)

Department of Urology, Hospital Universitário Presidente Dutra-HUPD/UFMA, São Luís, Maranhão, Brazil.

B Mark Smithers (BM)

University of Queensland, Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
ORCID: 0000-0002-8333-8685

Simone Garzon (S)

Department of Surgery, Dentistry, Pediatrics, and Gynecology, University of Verona, Verona, Italy.

Oliver Haase (O)

Department of Surgery, University Medicine Berlin-Charité, Berlin, Germany.

Antonio Sommariva (A)

Veneto Institute of Oncology Institute Oncology Veneto, Istituto Di Ricovero e Cura a Carattere Scientifico, Padova, Italy.

Robert Fruscio (R)

Department of Medicine and Surgery, University of Milan Bicocca, Azienda Socio Sanitaria Territoriale Monza, Italy.

Francisco Martins (F)

Department of Urology, Centro Hospitalar Universitário Lisboa Norte, Hospital de Santa Maria, Lisbon, Portugal.

Pedro S de Oliveira (PS)

Department of Urology, Centro Hospitalar Universitário Lisboa Norte, Hospital de Santa Maria, Lisbon, Portugal.

Giovanni Battista Levi Sandri (GB)

Department of Surgery, ASL Frosinone, Frosinone, Italy.

Marco Clementi (M)

Department of Medicine, Health and Life, University of L'Aquila, L'Aquila, AQ, Italy.

Juan Astigueta (J)

Department of Urology, Universidad Privada Antenor Orrego, Trujillo, Perú.

Islam H Metwally (IH)

Surgical Oncology Department, Oncology Center Mansoura University (OCMU), Mansoura, Egypt.

Rasiah Bharathan (R)

Department of Gynaecological Oncology, Medical University of Vienna, Vienna, Austria.

Tarun Jindal (T)

Department of Uro-oncology, Narayana Super Speciality Hospital, Howrah, India.

Yasuhiro Nakamura (Y)

Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.

Hisham Abdel Mageed (H)

Surgical Oncology Department, National Cancer Institute Cairo University, Cairo, Egypt.

Sakthiushadevi Jeevarajan (S)

Department of Surgical Oncology, Regional Cancer Centre, Kanchipuram, Tamil Nadu, India.
ORCID: 0000-0003-0118-3825

Ramón Rodriguez Lay (R)

Clinic Urology Service, Complejo Hospitalario Metropolitano, Madrid, Panama.

Herney Andrés García-Perdomo (HA)

Division of Urology/Urooncology, Department of Surgery, School of Medicine, Universidad del Valle, Cali, Colombia.

Omaira Rodríguez González (O)

Chief of Surgical Department, Clínicas Caracas Hospital, Faculty of Medicine, Central University of Venezuela, Caracas, Venezuela.

Saum Ghodoussipour (S)

Sections of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

Inderbir Gill (I)

Catherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Giovanni E Cacciamani (GE)

Catherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Complications and adverse events in...
questionsmedicales.fr › Procédures de chirurgie opératoire › Lymphadénectomie › Complications and adverse events in...
questionsmedicales.fr › Maladies urogénitales › Tumeurs de l'appareil urogénital › Tumeurs de l'appareil génital mâle › Tumeurs du pénis › Complications and adverse events in...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Complications postopératoires › Complications and adverse events in...
questionsmedicales.fr › Maladies urogénitales › Tumeurs de l'appareil urogénital › Tumeurs de l'appareil génital féminin › Tumeurs de la vulve › Complications and adverse events in...
questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Pensée (activité mentale) › Prise de décision › Consensus › Complications and adverse events in...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Naevus et mélanomes › Mélanome › Complications and adverse events in...
questionsmedicales.fr › Sciences de l'information › Analyse des systèmes › Méthode Delphi › Complications and adverse events in...
questionsmedicales.fr › Régions du corps › Tronc › Abdomen › Canal inguinal › Complications and adverse events in...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Complications and adverse events in...